Panbio™ Dengue IgG Indirect ELISA

La prueba Panbio™ Dengue IgG Indirect ELISA se utiliza para la detección cualitativa de anticuerpos IgG contra los serotipos del antígeno del dengue (1, 2, 3 y 4) en suero como ayuda para el diagnóstico en laboratorios clínicos de pacientes con síntomas clínicos y exposición en el pasado indicativos de fiebre del dengue. El punto de corte de IgG se establece para detectar los niveles de IgG presentes en las infecciones pasadas y activas del virus del dengue.

Producto no disponible en todos los países. Por favor, consulte con su representante de ventas local sobre la disponibilidad en su área.

Dengue IgG Indirect Dengue IgG Indirect Dengue IgG Indirect

©2023 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.

Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement | Declaration for California Compliance Law.

Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only.  For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.